Anti-LMCD1 monoclonal antibody

Pre-made anti-LMCD1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LMCD1/LMCD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2575-Ab-1/ GM-Tg-hg-IP2575-Ab-2Anti-Human LMCD1 monoclonal antibodyHuman
GM-Tg-rg-IP2575-Ab-1/ GM-Tg-rg-IP2575-Ab-2Anti-Rat LMCD1 monoclonal antibodyRat
GM-Tg-mg-IP2575-Ab-1/ GM-Tg-mg-IP2575-Ab-2Anti-Mouse LMCD1 monoclonal antibodyMouse
GM-Tg-cynog-IP2575-Ab-1/ GM-Tg-cynog-IP2575-Ab-2Anti-Cynomolgus/ Rhesus macaque LMCD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2575-Ab-1/ GM-Tg-felg-IP2575-Ab-2Anti-Feline LMCD1 monoclonal antibodyFeline
GM-Tg-cang-IP2575-Ab-1/ GM-Tg-cang-IP2575-Ab-2Anti-Canine LMCD1 monoclonal antibodyCanine
GM-Tg-bovg-IP2575-Ab-1/ GM-Tg-bovg-IP2575-Ab-2Anti-Bovine LMCD1 monoclonal antibodyBovine
GM-Tg-equg-IP2575-Ab-1/ GM-Tg-equg-IP2575-Ab-2Anti-Equine LMCD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2575-Ab-1/ GM-Tg-hg-IP2575-Ab-2; GM-Tg-rg-IP2575-Ab-1/ GM-Tg-rg-IP2575-Ab-2;
GM-Tg-mg-IP2575-Ab-1/ GM-Tg-mg-IP2575-Ab-2; GM-Tg-cynog-IP2575-Ab-1/ GM-Tg-cynog-IP2575-Ab-2;
GM-Tg-felg-IP2575-Ab-1/ GM-Tg-felg-IP2575-Ab-2; GM-Tg-cang-IP2575-Ab-1/ GM-Tg-cang-IP2575-Ab-2;
GM-Tg-bovg-IP2575-Ab-1/ GM-Tg-bovg-IP2575-Ab-2; GM-Tg-equg-IP2575-Ab-1/ GM-Tg-equg-IP2575-Ab-2
Products NameAnti-LMCD1 monoclonal antibody
Formatmab
Target NameLMCD1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LMCD1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2575-Ag-1Recombinant multi-species LMCD1 protein
    ORF Viral VectorpGMLP000312human LMCD1 Lentivirus plasmid
    ORF Viral VectorvGMLP000312human LMCD1 Lentivirus particle


    Target information

    Target IDGM-IP2575
    Target NameLMCD1
    Gene ID29995,30937,494021,702382,476545,101081203,540474,100058957
    Gene Symbol and Synonymsdyxin,LIMD1,LMCD1
    Uniprot AccessionQ9NZU5,Q17QE2
    Uniprot Entry NameLMCD1_HUMAN,LMCD1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000071282
    Target ClassificationN/A

    The target: LMCD1, gene name: LMCD1, also named as . This gene encodes a member of the LIM-domain family of zinc finger proteins. The encoded protein contains an N-terminal cysteine-rich domain and two C-terminal LIM domains. The presence of LIM domains suggests involvement in protein-protein interactions. The protein may act as a co-regulator of transcription along with other transcription factors. Alternate splicing results in multiple transcript variants of this gene. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.